Integrated Filing — IndAS



General information about company

Scrip Code 531335
NSE Symbol ZYDUSWELL
MSEI Symbol NOTLISTED
ISIN INE768C01028
Name of company Zydus Wellness Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 03-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 15-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Consumer Products
Start date and time of board meeting 03-11-2026   11:00:00
End date and time of board meeting 03-11-2026   12:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 28-03-2025
Indicate Company website link for updated RPT policy of the Company https://zyduswellness.com/wp-content/uploads/2026/05/Policy-on-RPT28-03-2025.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 16,680.00 31,980.00
Other income 520.00 1,010.00
Total income 17,200.00 32,990.00
2 Expenses
(a) Cost of materials consumed 11,660.00 21,870.00
(b) Purchases of stock-in-trade 360.00 600.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (110.00) (80.00)
(d) Employee benefit expense 1,260.00 2,790.00
(e) Finance costs 340.00 640.00
(f) Depreciation, depletion and amortisation expense 630.00 1,260.00
(f) Other Expenses
1 Other expenses 1,850.00 3,960.00
2 Net gain on foreign currency transactions (50.00) (50.00)
Total other expenses 1,800.00 3,910.00
Total expenses 15,940.00 30,990.00
3 Total profit before exceptional items and tax 1,260.00 2,000.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,260.00 2,000.00
6 Tax expense
7 Current tax (20.00) 0.00
8 Deferred tax 120.00 290.00
9 Total tax expenses 100.00 290.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,160.00 1,710.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,160.00 1,710.00
17 Other comprehensive income net of taxes (10.00) (10.00)
18 Total Comprehensive Income for the period 1,150.00 1,700.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 6,360.00 6,360.00
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.36 0.54
Diluted earnings (loss) per share from continuing operations 0.36 0.54
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.36 0.54
Diluted earnings (loss) per share from continuing and discontinued operations 0.36 0.54
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4,400.00
Capital work-in-progress 130.00
Investment property 0.00
Goodwill 11,330.00
Other intangible assets 25,610.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 3,67,160.00
Trade receivables, non-current 0.00
Loans, non-current 4,010.00
Other non-current financial assets
1 Other financial assets 30.00
Total of other non-current financial assets 30.00
Total non-current financial assets 3,71,200.00
Deferred tax assets (net) 1,600.00
Other non-current assets
1 Other non-current assets 440.00
2 Assets for tax [net] 310.00
Total of other non-current assets 750.00
Total non-current assets 4,15,020.00
2 Current assets
Inventories 3,770.00
Current financial asset
Current investments 2,490.00
Trade receivables, current 6,970.00
Cash and cash equivalents 170.00
Bank balance other than cash and cash equivalents 40.00
Loans, current 400.00
Other current financial assets
Total of other current financial assets 2,100.00
Total current financial assets 12,170.00
Current tax assets (net) 0.00
Other current assets
1 Other current assets 870.00
Total of other current assets 870.00
Total current assets 16,810.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 4,31,830.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 6,360.00
Other equity 3,94,780.00
Total equity attributable to owners of parent 4,01,140.00
Non controlling interest
Total equity 4,01,140.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 17,100.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 130.00
2 Other financial liabilities 90.00
Total of other non-current financial liabilities 220.00
Total non-current financial liabilities 17,320.00
Provisions, non-current 680.00
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 18,000.00
Current liabilities
Current financial liabilities
Borrowings, current 5,000.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1,020.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 4,670.00
Total Trade payable 5,690.00
Other current financial liabilities
1 Other financial liabilities 1,540.00
2 Lease liabilities 40.00
Total of other current financial liabilities 1,580.00
Total current financial liabilities 12,270.00
Other current liabilities 220.00
1 Other current liabilities 220.00
Total of other current liabilities 220.00
Provisions, current 200.00
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 12,690.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 30,690.00
Total equity and liabilites 4,31,830.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement loss on cost employment defined benefit plan (10.00) (10.00)
Total Amount of items that will not be reclassified to profit and loss (10.00) (10.00)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (10.00) (10.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,000.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 640.00
Adjustments for decrease (increase) in inventories (940.00)
Adjustments for decrease (increase) in trade receivables, current (4,220.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (630.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 1,400.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 540.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,260.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (40.00)
Adjustments for dividend income 0.00
Adjustments for interest income 170.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (10.00)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 30.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (2,140.00)
Net cash flows from (used in) operations (140.00)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 150.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (290.00)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 40.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 60.00
Purchase of property, plant and equipment 320.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 350.00
Cash receipts from repayment of advances and loans made to other parties 2,530.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 180.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (2,480.00)
Net cash flows from (used in) investing activities (420.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 4,200.00
Repayments of borrowings 0.00
Payments of lease liabilities 0.00
Dividends paid 3,820.00
Interest paid 180.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (30.00)
Net cash flows from (used in) financing activities 170.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (540.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (540.00)
Cash and cash equivalents cash flow statement at beginning of period 710.00
Cash and cash equivalents cash flow statement at end of period 170.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Sale of goods or services 28,371.60 Approved 28,371.60 0.00 0.00
2 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Sale of fixed assets 28.20 Approved 28.20 0.00 0.00
3 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Any other transaction Royalty income 2,388.40 Approved 2,388.40 0.00 0.00
4 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Interest paid 500.20 Approved 500.20 0.00 0.00
5 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Any other transaction Processing charges income 26.00 Approved 26.00 0.00 0.00
6 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Purchase of goods or services 622.70 Approved 622.70 0.00 0.00
7 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Purchase of fixed assets 1.50 Approved 1.50 0.00 0.00
8 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 1,566.90 5,581.40
9 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Any other transaction Intercorporate loan taken 4,200.00 Approved 4,200.00 0.00 0.00 Loan 6.2900 Upto 5 years Unsecured Business Purpose Textual Information(1)
10 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Any other transaction Outstanding loan payable including interest accrued but not due 0.00 Approved 0.00 12,900.00 17,550.20 Loan 6.3600 Upto 5 years Unsecured Business Purpose Textual Information(2)
11 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Sale of goods or services 377.40 Approved 377.40 0.00 0.00
12 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Interest received 123.50 Approved 123.50 0.00 0.00
13 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Any other transaction Reimbursement of expenses recovered 25.60 Approved 25.60 0.00 0.00
14 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 408.80 728.50
15 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Any other transaction Outstanding loan receivable including interest accrued but not due 0.00 Approved 0.00 3,792.00 3,832.00 Loan 6.4100 Upto 5 years Unsecured Business Purpose Textual Information(3)
16 Zydus Wellness Limited Zydus Lifesciences Limited Holding Company Any other transaction Purchase of services 48.00 Approved 48.00 0.00 0.00
17 Zydus Wellness Limited Zydus Lifesciences Limited Holding Company Any other transaction Reimbursement of expenses paid 11.50 Approved 11.50 0.00 0.00
18 Zydus Wellness Limited Zydus Lifesciences Limited Holding Company Any other transaction Payable other than loan 0.00 Approved 0.00 50.30 60.20
19 Zydus Wellness Limited Zydus Healthcare Limited Fellow Subsidiary Any other transaction Purchase of services 16.80 Approved 16.80 0.00 0.00
20 Zydus Wellness Limited Zydus Healthcare Limited Fellow Subsidiary Sale of fixed assets 0.60 Approved 0.60 0.00 0.00
21 Zydus Wellness Limited Alidac UK Limited Subsidiary Sale of goods or services 834.50 Approved 834.50 0.00 0.00
22 Zydus Wellness Limited Alidac UK Limited Subsidiary Any other transaction Intercorporate loan repaid 2,499.60 Approved 2,499.60 0.00 0.00
23 Zydus Wellness Limited Alidac UK Limited Subsidiary Interest received 5.70 Approved 5.70 0.00 0.00
24 Zydus Wellness Limited Alidac UK Limited Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 381.80 413.70
25 Zydus Wellness Limited Alidac UK Limited Subsidiary Any other transaction Outstanding loan receivable including interest accrued but not due 0.00 Approved 0.00 2,512.60 0.00 Loan 5.6600 Upto 2 years Unsecured Business Purpose Textual Information(4)
26 Zydus Wellness Limited Mukesh M Patel & Co. Enterprises Significantly Influenced by Directors of Holding Company Any other transaction Purchase of services 8.50 Approved 8.50 0.00 0.00
27 Zydus Wellness Limited Dr. Sharvil P. Patel Non -Executive Chairman Any other transaction Sitting fees 4.00 Approved 4.00 0.00 0.00
28 Zydus Wellness Limited Mr. Tarun Arora Chief Executive Officer & Whole Time Director Remuneration 85.40 Approved 85.40 0.00 0.00
29 Zydus Wellness Limited Mr. Umesh V. Parikh Chief Financial Officer Remuneration 121.90 Approved 121.90 0.00 0.00
30 Zydus Wellness Limited Mr. Nandish Joshi Company Secretary Remuneration 11.70 Approved 11.70 0.00 0.00
31 Zydus Wellness Products Limited Zydus Lifesciences Limited Holding Company Sale of goods or services 5.20 Approved 5.20 0.00 0.00
32 Zydus Wellness Products Limited Zydus Lifesciences Limited Holding Company Any other transaction Processing charges income 0.50 Approved 0.50 0.00 0.00
33 Zydus Wellness Products Limited Zydus Lifesciences Limited Holding Company Any other transaction Purchase of services 130.20 Approved 130.20 0.00 0.00
34 Zydus Wellness Products Limited Zydus Lifesciences Limited Holding Company Any other transaction Reimbursement of expenses paid 115.60 Approved 115.60 0.00 0.00
35 Zydus Wellness Products Limited Zydus Lifesciences Limited Holding Company Any other transaction Reimbursement of expenses recovered 8.00 Approved 8.00 0.00 0.00
36 Zydus Wellness Products Limited Zydus Lifesciences Limited Holding Company Any other transaction Payable other than loan 0.00 Approved 0.00 50.30 262.30
37 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Sale of goods or services 1,639.10 Approved 1,639.10 0.00 0.00
38 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Any other transaction Royalty income 23.50 Approved 23.50 0.00 0.00
39 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Any other transaction Reimbursement of expenses recovered 97.90 Approved 97.90 0.00 0.00
40 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 408.80 4,015.50
41 Zydus Wellness Products Limited Comfort Click Limited Subsidiary Sale of goods or services 413.50 Approved 413.50 0.00 0.00
42 Zydus Wellness Products Limited Comfort Click Limited Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 0.00 413.50
43 Zydus Wellness Products Limited Zydus Healthcare Limited Fellow Subsidiary Sale of goods or services 114.30 Approved 114.30 0.00 0.00
44 Zydus Wellness Products Limited Zydus Healthcare Limited Fellow Subsidiary Sale of fixed assets 1.10 Approved 1.10 0.00 0.00
45 Zydus Wellness Products Limited Zydus Healthcare Limited Fellow Subsidiary Any other transaction Processing charges income 82.50 Approved 82.50 0.00 0.00
46 Zydus Wellness Products Limited Zydus Healthcare Limited Fellow Subsidiary Purchase of goods or services 765.00 Approved 765.00 0.00 0.00
47 Zydus Wellness Products Limited Zydus Healthcare Limited Fellow Subsidiary Any other transaction Purchase of services 67.20 Approved 67.20 0.00 0.00
48 Zydus Wellness Products Limited Zydus Healthcare Limited Fellow Subsidiary Any other transaction Royalty expense 80.80 Approved 80.80 0.00 0.00
49 Zydus Wellness Products Limited Zydus Healthcare Limited Fellow Subsidiary Any other transaction Payable other than loan 0.00 Approved 0.00 0.00 178.40
50 Zydus Wellness Products Limited LM Manufacturing India Private Limited Fellow Subsidiary Any other transaction Sale of services 21.00 Approved 21.00 0.00 0.00
51 Zydus Wellness Products Limited LM Manufacturing India Private Limited Fellow Subsidiary Any other transaction Reimbursement of expenses recovered 3.90 Approved 3.90 0.00 0.00
52 Zydus Wellness Products Limited LM Manufacturing India Private Limited Fellow Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 0.70 0.70
53 Zydus Wellness Products Limited Zydus MedTech Private Limited Fellow Subsidiary Any other transaction Sale of services 24.60 Approved 24.60 0.00 0.00
54 Zydus Wellness Products Limited Zydus MedTech Private Limited Fellow Subsidiary Any other transaction Reimbursement of expenses recovered 2.90 Approved 2.90 0.00 0.00
55 Zydus Wellness Products Limited Zydus MedTech Private Limited Fellow Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 3.90 19.70
56 Zydus Wellness Products Limited Mr. Tarun Arora Whole Time Director Remuneration 392.90 Approved 392.90 0.00 0.00
57 Zydus Wellness Products Limited Mukesh M Patel & Co. Enterprises Significantly Influenced by Directors of Holding Company Any other transaction Purchase of services 11.00 Approved 11.00 0.00 0.00
58 Zydus Wellness Products Limited Cadmach Machinery Company Private Limited Enterprises Significantly Influenced by Directors of Holding Company Purchase of goods or services 3.80 Approved 3.80 0.00 0.00
59 Zydus Wellness Products Limited Indifoss Analytical Private Limited Enterprises Significantly Influenced by Directors of Holding Company Purchase of goods or services 3.50 Approved 3.50 0.00 0.00
60 Zydus Wellness Products Limited Indifoss Analytical Private Limited Enterprises Significantly Influenced by Directors of Holding Company Purchase of fixed assets 0.90 Approved 0.90 0.00 0.00
61 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises Significantly Influenced by Directors of Holding Company Sale of goods or services 1,467.10 Approved 1,467.10 0.00 0.00
62 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises Significantly Influenced by Directors of Holding Company Any other transaction Reimbursement of expenses paid 293.40 Approved 293.40 0.00 0.00
63 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises Significantly Influenced by Directors of Holding Company Any other transaction Receivable other than loan 0.00 Approved 0.00 0.00 654.60
64 Zydus Wellness Products Limited Zydus Wellness Sikkim Employees Group Gratuity Scheme Post Employment Benefits Plan Any other transaction Contributions during the period (includes Employee's share and contribution) 8.00 Approved 8.00 0.00 0.00
65 Zydus Wellness Products Limited Heinz India Private Limited Pension Fund Post Employment Benefits Plan Any other transaction Contributions during the period (includes Employee's share and contribution) 23.90 Approved 23.90 0.00 0.00
66 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Any other transaction Purchase of services 5.70 Approved 5.70 0.00 0.00
67 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Any other transaction Reimbursement of expenses recovered 6.00 Approved 6.00 0.00 0.00
68 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Any other transaction Reimbursement of expenses paid 1.90 Approved 1.90 0.00 0.00
69 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Any other transaction Payable other than loan 0.00 Approved 0.00 0.00 10.70
70 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 12.20 0.00
71 Zydus Wellness International DMCC Zydus Wellness General Trading DWC LLC Subsidiary Any other transaction Reimbursement of expenses recovered 37.30 Approved 37.30 0.00 0.00
72 Zydus Wellness International DMCC Zydus Wellness General Trading DWC LLC Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 0.00 37.30
73 Zydus Wellness International DMCC Zydus Wellness Trading LLC Subsidiary Any other transaction Reimbursement of expenses recovered 26.60 Approved 26.60 0.00 0.00
74 Zydus Wellness International DMCC Zydus Wellness Trading LLC Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 0.00 26.60
75 Comfort Click Ltd Comfort Click Ltd, Ireland Subsidiary Any other transaction Sale of goods 119.40 Approved 119.40 0.00 0.00
76 Comfort Click Ltd Comfort Click Ltd, Ireland Subsidiary Any other transaction Reimbursement of expenses recovered 126.60 Approved 126.60 0.00 0.00
77 Comfort Click Softech Pvt.Ltd Comfort Click Ltd Subsidiary Any other transaction Sale of Services 1,788.60 Approved 1,788.60 0.00 0.00
78 Comfort Click Softech Pvt.Ltd Zydus Wellness Products Limited Subsidiary Any other transaction Transfer of whole Support Service Business 58.00 Approved 58.00 0.00 0.00
79 Comfort Click Ltd Zydus Wellness (EU) Lmited Subsidiary Any other transaction Reimbursement of expenses recovered 6.50 Approved 6.50 0.00 0.00
80 Comfort Click Ltd Zydus Wellness (EU) Lmited Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 0.00 6.50
81 Comfort Click Ltd Comfort Click LLC Subsidiary Any other transaction Reimbursement of expenses recovered 2.20 Approved 2.20 0.00 0.00
82 Comfort Click Ltd, Ireland Comfort Cilck Ltd Subsidiary Any other transaction Reimbursement of expenses recovered 17,216.00 Approved 17,216.00 0.00 0.00
83 Alidac UK Ltd Comfort Cilck Ltd Subsidiary Any other transaction Reimbursement of expenses recovered 1.00 Approved 1.00 0.00 0.00
84 Comfort Click Ltd Comfort Click Ltd, Ireland Subsidiary Any other transaction Payable other than loan 0.00 Approved 0.00 1,373.40 1,379.50
85 Comfort Click Ltd Comfort Click Softech Pvt.Ltd Subsidiary Any other transaction Payable other than loan 0.00 Approved 0.00 303.30 0.00
86 Comfort Click Ltd Comfort Click LLC Subsidiary Any other transaction Receivable other than loan 0.00 Approved 0.00 0.00 41.00
Total value of transaction during the reporting period 65,510.40



Text Block

Textual Information(1) 6MTB+70bps
Textual Information(2) 6m Tbill+70bps, 6m Tbill+90bps
Textual Information(3) 1Yr SOFR + 210BPS, 6M SOFR + 285BPS
Textual Information(4) 6m SONIA+ 215bps


Format for Disclosing Outstanding Default on Loans and Debt Securities

Amount in (Lakhs)

<
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 5,000.00
B Of the total amount outstanding, amount of default as on date 0.00
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
3. Total financial indebtedness of the listed entity including short-term and long-term debt 5,000.00